what are glp 1 agonists Can one drug do it all? Reviewing the expanding clinical universe of GLP-1 GLP-1 Receptor Agonist Shortage: Challenges

Furthermore, myogenic progenitors derived from C9orf72 ALS patients displayed increased susceptibility to oxidative stress and dysregulation of mitochondrial genes, and these events were associated with mitochondrial abnormalities and toxicity (Lynch et al., 2019)

Cousen et al

In the nigrostriatal tract system, dopamine undergoes autooxidation or oxidative deamination by monoamine oxidase-B, both of which aggravates with age, leading to increased production of peroxides and hydroxyl radicals 41

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial

doi: 10.1056/NEJMoa1411892 124 ButlerAEJansonJBonner-WeirSRitzelRRizzaRAButlerPC